A Second Chance at Registration

Origent leverages advanced predictive analytics to rescue failed drug programs in ALS, Alzheimer’s, and other neurodegenerative diseases.

Managing Drug Development Risk through Better Foresight

Predicting patient-level dynamics allows researchers, drug developers, and investors better manage risks and reduce the costs of drug discovery.

Unparalleled ALS Predictive Modeling Capabilities

Origent's suite of predictive models accurately predict the progression of ALS and ALS symptoms.

Informed Discovery

Origent's clinical trial analysis tools help biotech firms conduct more cost efficient clinical trials and inform new experiments.

Fail Faster

We help pharmaceutical companies identify the most promising prospects in their drug development pipeline earlier, to eliminate failing projects and better prioritize scarce resources.

Invest Confidently

Origent has a unique method for helping biotech investors evaluate clinical trial data during due diligence.

Managing Drug Development Risk through Better Foresight

Origent Logo WHITE for banner